MedElevator Войти в исследования
← Поиск публикаций
The Journal of arthroplasty · 2026

Obesity and Chronic Opioids Were Not Negatively Associated With Achieving Centers for Medicare and Medicaid Services Mandated Thresholds for Hip Disability and Osteoarthritis Outcome Score for Joint Replacement Scores After Primary Total Hip Arthroplasty.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Buller Leonard T, Luo T David, Deckard Evan R, Meding John B, Meneghini R Michael

Аннотация

BACKGROUND: The Centers for Medicare and Medicaid Services (CMS) will begin mandating Hip Disability and Osteoarthritis Outcome Score, Joint Replacement (HOOS JR) improvement thresholds for total hip arthroplasty (THA) starting in 2026 and have established a 22-point improvement target. Surgeon and institutional data will be publicly reported, and some may avoid patients who have risk factors for poor outcomes such as chronic opioid use. The purpose of this study was to identify predictors of HOOS JR improvement based on the CMS-mandated HOOS JR improvement threshold.

METHODS: A total of 1,682 consecutive primary THAs were retrospectively reviewed. Patient data, including the presence of fibromyalgia, autoimmune disease, osteonecrosis, depression, chronic narcotic usage, and lumbar spine disease were manually extracted from a statewide health care system. Predictors of improvement in HOOS JR total scores were evaluated accounting for the minimal clinically important difference and substantial clinical benefit thresholds established by CMS. Multivariable statistical analyses were performed with P < 0.05 indicating statistical significance.

RESULTS: At a mean clinical follow-up of 22 months, mean improvement in HOOS JR score from preoperative baseline was 36.0 points (range, -44 to 100). A total of 76.8% of patients met the HOOS JR substantial clinical benefit of 22 suggested by CMS, and 94.5% met the minimal clinically important difference threshold of 6.0. In multivariable analysis, only increasing body mass index was associated with greater improvement in HOOS JR scores (P = 0.006). Interestingly, chronic narcotic use was not associated with achieving HOOS JR thresholds or improvement scores (P ≥ 0.336, statistical power ≥ 91.6%).

CONCLUSIONS: In this single-surgeon retrospective cohort, obesity and preoperative chronic opioid use were not negatively associated with achievement of HOOS JR improvement score thresholds. Furthermore, with the variables collected in this study, very few patient characteristics demonstrated strong discriminatory ability for the CMS 22-point HOOS JR improvement threshold.

LEVEL OF EVIDENCE: III.